Safety and Effectiveness of Liv.52 DS in Patients With Varied Hepatic Disorders: An Open-Label, Multi-centre, Phase IV Study. - Shivnitwar SK; Gilada I; Rajkondawar AV; Ojha SK; Katiyar S; Arya N; Babu UV; Kumawat R (Cureus, 2024)